$187 Million is the total value of Prosight Management, LP's 38 reported holdings in Q3 2022. The portfolio turnover from Q2 2022 to Q3 2022 was 100.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| PRTA | Sell | PROTHENA CORP PLC | $19,468,000 | +30.4% | 321,093 | -41.6% | 10.43% | -11.4% |
| HZNP | New | HORIZON THERAPEUTICS PUB L | $18,753,000 | – | 303,000 | +100.0% | 10.05% | – |
| GLPG | Buy | GALAPAGOS NVspon adr | $17,269,000 | -16.1% | 405,000 | +9.8% | 9.25% | -43.0% |
| KZR | Buy | KEZAR LIFE SCIENCES INC | $11,433,000 | +9.5% | 1,327,899 | +5.2% | 6.12% | -25.6% |
| ALKS | New | ALKERMES PLC | $11,213,000 | – | 502,150 | +100.0% | 6.01% | – |
| ALBO | Buy | ALBIREO PHARMA INC | $9,510,000 | +2.4% | 491,244 | +5.0% | 5.10% | -30.4% |
| MGTX | Buy | MEIRAGTX HLDGS PLC | $9,279,000 | +24.3% | 1,103,365 | +11.9% | 4.97% | -15.5% |
| KALV | Sell | KALVISTA PHARMACEUTICALS INC | $7,691,000 | -4.8% | 530,062 | -35.4% | 4.12% | -35.3% |
| CRL | Buy | CHARLES RIV LABS INTL INC | $6,538,000 | +11.1% | 33,220 | +20.8% | 3.50% | -24.4% |
| ALDX | Sell | ALDEYRA THERAPEUTICS INC | $6,466,000 | -18.4% | 1,210,800 | -39.0% | 3.46% | -44.5% |
| HUM | New | HUMANA INC | $6,210,000 | – | 12,800 | +100.0% | 3.33% | – |
| MIRM | Buy | MIRUM PHARMACEUTICALS INC | $5,988,000 | +90.5% | 285,000 | +76.4% | 3.21% | +29.5% |
| THC | Buy | TENET HEALTHCARE CORP | $5,261,000 | +97.4% | 102,000 | +101.2% | 2.82% | +34.2% |
| JNJ | New | JOHNSON & JOHNSON | $5,179,000 | – | 31,704 | +100.0% | 2.78% | – |
| Buy | QUIDELORTHO CORP | $4,496,000 | -0.7% | 62,900 | +35.0% | 2.41% | -32.4% | |
| CUE | Sell | CUE BIOPHARMA INC | $3,447,000 | -16.4% | 1,545,573 | -6.6% | 1.85% | -43.1% |
| New | PROTHENA CORP PLCcall | $3,219,000 | – | 53,100 | +100.0% | 1.72% | – | |
| RCKT | Sell | ROCKET PHARMACEUTICALS INC | $3,192,000 | -16.2% | 200,000 | -27.7% | 1.71% | -43.0% |
| STTK | Buy | SHATTUCK LABS INC | $3,026,000 | -26.9% | 1,120,776 | +9.9% | 1.62% | -50.3% |
| ORIC | New | ORIC PHARMACEUTICALS INC | $2,996,000 | – | 936,334 | +100.0% | 1.60% | – |
| INCY | New | INCYTE CORP | $2,696,000 | – | 40,450 | +100.0% | 1.44% | – |
| OMCL | New | OMNICELL COM | $2,672,000 | – | 30,700 | +100.0% | 1.43% | – |
| AVTR | New | AVANTOR INC | $2,404,000 | – | 122,668 | +100.0% | 1.29% | – |
| BAX | New | BAXTER INTL INC | $2,101,000 | – | 39,000 | +100.0% | 1.13% | – |
| RYTM | New | RHYTHM PHARMACEUTICALS INC | $1,960,000 | – | 80,000 | +100.0% | 1.05% | – |
| ONEM | Sell | 1LIFE HEALTHCARE INC | $1,821,000 | -68.0% | 106,200 | -85.4% | 0.98% | -78.2% |
| New | CASSAVA SCIENCES INCput | $1,501,000 | – | 35,900 | +100.0% | 0.80% | – | |
| BCRX | Sell | BIOCRYST PHARMACEUTICALS INC | $1,434,000 | -23.3% | 113,800 | -35.6% | 0.77% | -47.9% |
| ARDX | Sell | ARDELYX INC | $1,340,000 | +5.0% | 1,126,127 | -47.9% | 0.72% | -28.6% |
| EOLS | New | EVOLUS INC | $1,290,000 | – | 160,200 | +100.0% | 0.69% | – |
| PRQR | Buy | PROQR THRAPEUTICS N V | $1,277,000 | -3.8% | 1,716,290 | +0.5% | 0.68% | -34.6% |
| ADCT | New | ADC THERAPEUTICS SA | $1,194,000 | – | 247,630 | +100.0% | 0.64% | – |
| GRPH | New | GRAPHITE BIO INC | $1,130,000 | – | 356,445 | +100.0% | 0.60% | – |
| SBTX | Sell | SILVERBACK THERAPEUTICS INC | $1,036,000 | -28.4% | 196,257 | -42.5% | 0.56% | -51.3% |
| ABCL | New | ABCELLERA BIOLOGICS INC | $856,000 | – | 86,504 | +100.0% | 0.46% | – |
| New | R1 RCM INC | $595,000 | – | 32,113 | +100.0% | 0.32% | – | |
| SPOK | New | SPOK HLDGS INC | $497,000 | – | 65,000 | +100.0% | 0.27% | – |
| MRVI | New | MARAVAI LIFESCIENCES HLDGS I | $218,000 | – | 8,540 | +100.0% | 0.12% | – |
| Exit | COGNITION THERAPEUTICS INC | $0 | – | -120,198 | -100.0% | -0.20% | – | |
| APEN | Exit | APOLLO ENDOSURGERY INC | $0 | – | -90,176 | -100.0% | -0.26% | – |
| INMD | Exit | INMODE LTD | $0 | – | -45,000 | -100.0% | -0.79% | – |
| GBT | Exit | GLOBAL BLOOD THERAPEUTICS IN | $0 | – | -101,847 | -100.0% | -2.56% | – |
| Exit | 1LIFE HEALTHCARE INCcall | $0 | – | -440,000 | -100.0% | -2.72% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2022-11-14
Signatures
The EDGAR filing(s) were signed by:
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| ALDEYRA THERAPEUTICS INC | 19 | Q2 2023 | 6.2% |
| ALBIREO PHARMA INC | 18 | Q4 2022 | 9.2% |
| MEIRAGTX HOLDINGS PLC | 18 | Q3 2023 | 6.3% |
| KEZAR LIFE SCIENCES INC | 17 | Q3 2023 | 8.2% |
| ARENA PHARMACEUTICALS INC | 16 | Q4 2021 | 8.2% |
| IOVANCE BIOTHERAPEUTICS INC | 16 | Q1 2022 | 7.7% |
| CENTENE CORP DEL | 16 | Q3 2023 | 5.3% |
| CUE BIOPHARMA INC | 14 | Q1 2023 | 5.6% |
| PROTHENA CORP PLC | 13 | Q3 2023 | 13.6% |
| ZIMMER BIOMET HOLDINGS INC | 13 | Q3 2021 | 9.8% |
View Prosight Management, LP's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| EXICURE, INC. | February 14, 2022 | 2,426,508 | 2.2% |
| Aldeyra Therapeutics, Inc. | February 12, 2021 | 908,488 | 2.3% |
| Teligent, Inc. | February 14, 2020 | 1,484,527 | 2.8% |
| Cidara Therapeutics, Inc. | February 14, 2019 | 245,764 | 0.9% |
| Eiger BioPharmaceuticals, Inc.Sold out | February 14, 2019 | 0 | 0.0% |
| Millendo Therapeutics, Inc. | February 14, 2019 | 256,739 | 2.0% |
| OvaScience, Inc. | October 26, 2018 | 1,991,100 | 5.6% |
| CHIMERIX INC | February 13, 2018 | 1,478,519 | 3.1% |
| Harvard Apparatus Regenerative Technology, Inc. | February 12, 2016 | 184,360 | 1.4% |
View Prosight Management, LP's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-13 |
| SC 13G/A | 2024-02-13 |
| SC 13G/A | 2024-02-13 |
| SC 13G/A | 2024-02-13 |
| SC 13G/A | 2024-02-13 |
| SC 13G/A | 2024-02-13 |
| SC 13G | 2024-01-02 |
| 13F-HR | 2023-11-14 |
| SC 13G | 2023-09-01 |
View Prosight Management, LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.